Good point, however, the company have reported activity to expand the technology for other cancers.
December 2022 - https://rhythmbio.com/file/1624/325?p=220
"Rhythm has further progressed its feasibility program now confirming a second bioanalytical partner, the
Baker Institute, who have been engaged to advance proof of concept for a second cancer program. The
Baker Institute is an independent, internationally renowned medical research facility, with a history
spanning more than 96 years, focusing on diagnosis, prevention and treatment of diabetes, cardiovascular
disease and associated metabolic diseases. The Company’s will focus on feasibility, testing and validation
of the biomarkers of interest identified by Rhythm."
Announcements to update progress could occur at any time...
Where is RHY headed?, page-38
-
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RHY (ASX) to my watchlist
|
|||||
Last
5.8¢ |
Change
-0.003(4.92%) |
Mkt cap ! $14.41M |
Open | High | Low | Value | Volume |
6.1¢ | 6.1¢ | 5.8¢ | $9.662K | 161.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 267838 | 5.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.9¢ | 175 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 267838 | 0.058 |
2 | 22855 | 0.056 |
1 | 54545 | 0.055 |
1 | 150000 | 0.052 |
1 | 68500 | 0.051 |
Price($) | Vol. | No. |
---|---|---|
0.059 | 175 | 1 |
0.060 | 55000 | 1 |
0.062 | 48450 | 1 |
0.066 | 79998 | 1 |
0.070 | 415394 | 3 |
Last trade - 15.57pm 19/07/2024 (20 minute delay) ? |
Featured News
RHY (ASX) Chart |